相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Increased number of B-cells in the red pulp of the spleen in ITP
Bob Olsson et al.
ANNALS OF HEMATOLOGY (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Defective regulatory B-cell compartment in patients with immune thrombocytopenia
Xiaojuan Li et al.
BLOOD (2012)
Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia
Bob Olsson et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Memory CD8(+) T cell differentiation
Joshua J. Obar et al.
YEAR IN IMMUNOLOGY 2 (2010)
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy
Leola Chow et al.
BLOOD (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic
F. Perosa et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1
Bob Olsson et al.
BLOOD (2008)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues
Victor Appay et al.
CYTOMETRY PART A (2008)
Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies
C. Zhao et al.
HAEMATOLOGICA (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura
Shuguang Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Nichola Cooper et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules
Hiroshi Takata et al.
JOURNAL OF IMMUNOLOGY (2006)
Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura
F Zhang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Brief report - Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response
FP Panitsas et al.
BLOOD (2004)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
R McMillan et al.
BLOOD (2004)
Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells
S Coito et al.
STEM CELLS AND DEVELOPMENT (2004)
Constitutive expression of CCR7 directs effector CD8 T cells into splenic white pulp and impairs functional activity
H Unsoeld et al.
JOURNAL OF IMMUNOLOGY (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
B Olsson et al.
NATURE MEDICINE (2003)
New methods and software tools for high throughput CDR3 spectratyping. Application to T lymphocyte repertoire modifications during experimental malaria
A Collette et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura
M Kuwana et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl+ K562 leukemic cells by Gab2
JF Dorsey et al.
BLOOD (2002)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)